Diabetes drug could help Parkinsons sufferers

04 Août, 2017, 15:21 | Author: Cyril Hebras
  • People with Parkinson’s who took Exenatide – an existing diabetes medication- for around a year had better motor skills than those who took a placebo

People with Parkinson's who took Exenatide - an existing diabetes medication - for around a year had better motor skills than those who took a placebo. This research did not determine conclusively whether the drug modified the disease, however, so this will be investigated more fully in the next stage.

Parkinson's disease, which affects 127,000 people in the United Kingdom, causes progressive damage to the brain over time and cells that produce dopamine hormone - a chemical that helps control body movement - are lost.

"This is a very promising finding, as the drug holds potential to affect the course of the disease itself, and not merely the symptoms", said the study's senior author, Professor Tom Foltynie, a consultant neurologist at the NHNN.

'With existing treatments, we can relieve most of the symptoms for some years, but the disease continues to worsen'.

The patients injected themselves once a week for 48 weeks with either Exenatide or a placebo, in addition to their regular medications. Symptoms typically don't become apparent until over 70% of the brain's dopamine-producing cells have been affected.

Professor Foltynie said Exenatide acts on a receptor in the brain that helps neurons survive by reducinhg inflammation and boosting the mitochondria that powers them.

Over a period of 48 weeks, the control group continued to decline (as would be expected) but those taking exenatide remained stable and showed less degeneration in brain scans. The advantage of 4 points, on a 132-point scale of measures such as tremors, agility and speech, was statistically significant.

L'iPhone 8 enregistrera des vidéos en 4K à 60 images par seconde
Néanmoins, cela laisse entendre qu'Apple a au moins considéré l'ajout d'une telle caractéristique sur les deux caméras. C'est une ligne de code bien précise qui a aiguillé les développeurs du site: is4k60VideoSupportedForDevice.


Relative Momentum Trending Higher For Royal Dutch Shell PLC (RDSB.L)
On the other side, a stock may be considered to be in a downtrend if trading below the moving average and sloping downward. The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of stock price movements.


Kelechi Iheanacho débarque à Leicester City — Mercato
Selon la BBC, le montant du transfert d'Iheanacho, âgé de 20 ans, sera de 25 millions de livres (28 millions d'euros). Iheanacho a marqué à 21 reprises en 64 matchs avec Manchester City.


David Dexter, deputy director of research at Parkinson's United Kingdom, said: 'These interesting results build upon an earlier, smaller trials and offer further encouragement that diabetes treatments could provide new treatments for Parkinson's in the future'.

The study - the first randomised controlled trial of the drug in Parkinson's patients - adds to previous research which suggested the drug could improve motor function and modify the course of the disease.

The research is published in The Lancet today (FRI) and was funded by the Michael J. Fox Foundation for Parkinson's Research (MJFF).

"Using approved therapies for one condition to treat another, or drug repurposing, offers new avenues to speed Parkinson's therapeutic development", commented Dr Brian Fiske, senior vice president of research programmes at MJFF. "We also hope to learn why exenatide appears to work better for some patients than for others", said the study's first author, Dr Dilan Athauda (UCL Institute of Neurology).

Whether exenatide affects the underlying disease or just its symptoms is uncertain, the researchers say.

Parkinson's disease affects 1 in 500 people and is the second most common neurodegenerative disease worldwide. The condition results in muscle stiffness, slowness of movement, tremors, sleep disturbance, chronic fatigue and an impaired quality of life.

Conseillé:



Populaire

After repeal fails, 'task remains' to reform health care, says bishop
Has that helped fuel the growing opioid addiction crisis? There is no way we could have afforded any of this without Obamacare. With almost 38 million members and offices in every state, the District of Columbia, Puerto Rico, and the U.S.

'Google a offert 30 milliards pour Snapchat'
Enfin, Google pourrait enfin s'implanter sur un réseau social qui rencontre du succès ... Il y aurait désormais plus de publications sur Instagram Stories que sur Snapchat.

Phil Thompson predicts where Liverpool will finish next season
The headliners, however, have yet to move in either direction, despite the obscene amount of media space they've occupied.

Tucson-based Vector test launches rocket in Georgia
Vector Space Systems launched a small rocket from private property off Harriett's Bluff Road on Thursday that Camden County lauded as another step to establishing a spaceport there.

Karti Chidambaram moves Madras High Court against lookout notice issued by CBI
In May, CBI conducted raids on the residential and business premises of Karti in Chennai in connection with the case. In the picture shared on the tweet, he is seen congratulating Sivagangai district Congress leader at Karaikudi.

Alphabet Inc. (GOOGL) Earns "Hold" Rating from Pivotal Research
The information services provider reported $5.01 EPS for the quarter, missing the Zacks' consensus estimate of $8.25 by $3.24. Following the transaction, the director now directly owns 5,579 shares in the company, valued at approximately $5,198,958.52.

Trump's tweets are the best leverage we have on China — Sebastian Gorka
Sebastian Gorka, the president's tweets are the key to getting China to put increased pressure on the North Korean regime. But she has also acknowledged that Russia's engagement on the draft resolution would be the "true test".

Salman to appear in court next in October over Arms Act case
Along with Salman, Saif Ali Khan, Tabu, Sonali Bendre and Neelam were accused of poaching blackbucks on the night of October 1998. Parik after verification of documents as well as of the bail bonds, posted the matter for arguments on October 5.

Yirendai Ltd. (NYSE:YRD) Shares Down 12.2% on Disappointing Earnings
Renaissance Technologies LLC acquired a new stake in shares of Yirendai during the fourth quarter worth approximately $1,090,000. Finally, Parametric Portfolio Associates LLC purchased a new position in Yirendai during the first quarter worth about $362,000.

WestRock Co (WRK) EPS Estimated At $0.63
The business had revenue of $3.70 billion during the quarter, compared to analysts' expectations of $3.66 billion. The stock of OHR Pharmaceutical Inc (NASDAQ:OHRP) earned "Hold" rating by Brean Capital on Wednesday, August 10.